Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Alli Lifestyle Marketing Plan Could Prompt Copies – Researchers

This article was originally published in The Tan Sheet

Executive Summary

GlaxoSmithKline's marketing of alli as an addition to a healthy lifestyle and not as the complete solution to consumers' weight-loss needs could prompt other pharmaceutical companies to follow similar marketing plans, according to researchers

You may also be interested in...



Chattem Flexes Earnings Guidance After Strong Start For Core Brands

Strong sales in January and high expectations for product initiatives planned for the remainder of the year prompted Chattem to increase its fiscal 2008 earnings estimates, the firm's executives told analysts Jan. 29

Chattem Flexes Earnings Guidance After Strong Start For Core Brands

Strong sales in January and high expectations for product initiatives planned for the remainder of the year prompted Chattem to increase its fiscal 2008 earnings estimates, the firm's executives told analysts Jan. 29

Chattem Flexes Earnings Guidance After Strong Start For Core Brands

Strong sales in January and high expectations for product initiatives planned for the remainder of the year prompted Chattem to increase its fiscal 2008 earnings estimates, the firm's executives told analysts Jan. 29

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS100605

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel